“I am humbled and honoured to receive the ET’s Businesswoman of the Year Award. This recognition belongs to each and every one of our 25,00...

"Since the second stage closing could not be completed as per the agreed timelines, in the terms of the SPMA, InvaGen has received a notice...

In November 2017, there were 39 deals worth USD 3.2 billion.

At the second stage, InvaGen or its affiliates will acquire the remaining shares of Avenue's common stock, for up to USD 180 million in the...

Here is a list of top stocks that are likely to be in focus in today's trading session.

The approved product is a generic equivalent to the reference listed drug (RLD), Renvela tablets, 800 mg of Genzyme Corporation, said Cipla.

The company's tablets are generic versions of Valeant's Wellbutrin XL tablets in the same strengths, Cipla said.

The deal closure, that involved approvals from the US regulatory agencies, will see Cipla vault its sales from that market to around $400 m...

Elaborating on the pipeline for new drugs, Cipla said it has over 200 drugs under development with the top 50 projects having potential of ...

In an email response seeking comment, PuraCap said its complaint was publicly available at the US District Court for the Southern District ...

Indian markets are expected to trade in a range. Here is a list of twelve stocks which are likely to remain in focus today.

Acquisitions of two companies in the US will help Cipla increase its foothold in the market and has made analysts bullish on the counter.

We have had a good beginning in the US since our ‘go live’ in January 2015 and we expect to continue our growth trajectory there.

India Ratings & Research today said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based compan...

Cipla said the group, through its subsidiary Camber Pharmaceuticals Inc., will continue to strengthen its operations in the US.

Cipla shares climbed over 3% in morning trade after the company said its UK-based subsidiary, Cipla EU, will acquire two US-based companies.

Glenmark Pharmaceuticals Inc, US a subsidiary of Glenmark Pharmaceuticals has initiated the marketing and distribution of Nabumetone tablet...